XINT — Xintela AB Share News
0.000.00%
Last trade - 00:00- SEK200.68m
- SEK190.89m
- SEK2.28m
Brief: Flerie Invest Reach 41% Ownership In Xintela
Brief: Xintela Starts Clinical Study
Brief: Targinta Presents Positive Preclinical Data
Brief: Flerie Invest Makes Cash Offer To Shareholders In Xintela
Brief: Xintela Recommends Shareholders Not To Accept Flerie Invest's Offer
Brief: Xintela Q2 Loss Before Tax Widens To SEK 18.9 Mln
Brief: Xintela's Rights Issue is fully subscribed
Brief: Xintela Gets Approval For Clinical Study With XSTEM
Brief: Xintela's Targinta Obtains Patent Grant In Japan
Brief: Xintela Unit Engages Abzena For Production Of Targ9 And Targ10
Brief: Xintela Unit Selects Targ9 As Drug Candidate
Brief: Xintela Receives Loan Of SEK 3 Million
Brief: Xintela Q4 Pretax Loss Widens To SEK 26.6 Mln
Brief: Xintela And Scanvet Animal Health Sign Letter Of Intent
Brief: Xintela Secures Loan Of SEK 9 Mln
Brief: Xintela Q3 Loss Before Tax Widens To SEK 10.9 Mln
Brief: Xintela To Expand Clinical Development Of Xstem
Brief: Xintela Q2 Pre-tax Loss Widens To SEK 11.8 Mln
Brief: Xintela Signs Contract With Australian CRO For Clinical Study